2/10/2017 Federal Register, Volume 73 Issue 227 (Monday, November 24, 2008) [Federal Register Volume 73, Number 227 (Monday, November 24, 2008)] [Notices] [Pages 70999-71000] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: E8-27853] ENVIRONMENTAL PROTECTION AGENCY [FRL-8744-2; Docket ID No.

(ORDER LIST: 555 U.S.)

Scientific Workshop to Inform the Technical Work Plan for EPA's Response to NAS Comments on the Health Effects of Dioxin presented in EPA's Dioxin Reassessment Cincinnati, OH Date: February 18-20, 2009 Background/Workshop Objective At the request of the U.S.

DRAFT--DO NOT QUOTE OR CITE 5.

2/10/2017 https://www.fsis.usda.gov/wps/wcm/connect/fsis-content/intemet/main/topics/data-coNection-and-reports/chemistry/dioxin-related-activites Dioxin Related Activities General and Scientific Information q?

Cable Viewer Viewing cable 08BOGOTA229, FOREIGN INVESTMENT CONTINUES TO BOOM IN COLOMBIA If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others.

6.

Shearman FCPA Website: Cases: SEC v.

APPENDIX A.

3 February 2009 Draft Selection Criteria to identify Key In Vivo Mammalian Studies that Inform Dose-Response Modeling for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)a Study Feature Chemical, purity, matrix/medium Peer review Study design, execution, and reporting Study subject: species, strain, and sensitivity for given endpoint; litter; life stage; gender Exposure route Dose level Exposure frequency, duration, and timing Controls Response Statistical evaluation Selection Rationale Primary*3 Secondary^ TCDD-only doses included, purity specified, TCDD purity or matrix not clearly identified matrix in which TCDD is administered is identified Independently peer-reviewed, publicly available Supplementary materials accompanying peer-reviewed publication Clearly documented and consistent with standard Testing protocol provides incomplete toxicological principles, testing protocols, coverage of relevant endpoint-specific and practice (i.e., endpoint-appropriate, measures, particularly for negative findings particularly for negative findings) Mammalian species Mammalian species, in vivo, but only Strain and gender identified studying an artificially sensitive subject Animal age at beginning of treatment identified (e.g., knockout mouse) Litter confounders (within/between) accounted for Currently Excluded Studies of dioxin-like compounds (DLCs) or mixtures Not formally peer-reviewed; literature not publicly available Studies not meeting standard principles and practices Non-mammalian or not in vivo Oral Parenteral (e.g., intravenous, intramuscular, Inhalation, dermal, ocular intraperitoneal, subcutaneous) Lowest dose <200 ng/kg-d for noncancer endpoints and <1 ^g)/kg-d for cancer Lowest dose >200 ng/kg-d for noncancer endpoints, or >1.0 ^.g/kg-d for cancer Dosing regimen characterized and explained Characterization/explanation missing or cannot be determined Appropriate and well characterized Effect reported, but with no negative control Effect relevant to human health Magnitude outside range of normal variability Precursor effects, or adaptive responses Lethality potentially relevant to human health Clearly described and appropriate to the endpoint Limited statistical context and study design (e.g., per error variance, magnitude of effect) a NAS (2006) commented that the selection of data sets for quantitative dose-response modeling needed to be more transparent.

Cable Viewer Viewing cable 05BRASILIA3026, SLOW GOING ON BIOTECH, BUT MONSANTO LOOKING AT If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others.

United States Environmental Protection Agency_______________ Office of Research and Development Washington, DC 20460 Information Sheet 3 October 15, 2004 Update Dioxin Reassessment Process: What is the Status of the Reassessment and How Was the Reassessment Developed?

DRAFT DO NOT CITE OR QUOTE NCEA-I-0835 December 2003 NAS Review Draft www.epa.gov/ncea Chapter 8.

DRAFT DO NOT CITE OR QUOTE NCEA-I-0836 December 2003 NAS Review Draft www.epa.gov/ncea Chapter 9.

StAR - Stolen Asset Recovery Initiative - Corruption Cases - Senior Official at Ministry of Environment and Others / Monsanto Bollgard Cotton Case Jump to navigation Senior Official at Ministry of Environment and Others / Monsanto Bollgard Cotton Case Case Control Number: 70 Description : In 2005, the Monsanto company settled with the US authorities criminal and civil cases that arose in regards to improper payments made to Indonesian officials as part of the company's efforts to grow its Bollgard Cotton, a Genetically-Modified Organism, in South Sulawesi, Indonesia.